Paroxetine may prevent ROS damage in diabetes patients

12/16/2012 | RedOrbit

The antidepressant paroxetine appeared to stave off reactive oxygen species molecules associated with hyperglycemia in diabetes patients, according to a study in Diabetes. Researchers said the drug prevents ROS damage by lowering concentrations and suppressing production of superoxide.

View Full Article in:

RedOrbit

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN